Catherine Henckel1, Anna Revette2, Scott F Huntington3, James A Tulsky4, Gregory A Abel5, Oreofe O Odejide6. 1. Rutgers New Jersey Medical School, Newark, New Jersey, USA. 2. Dana-Farber/Harvard Cancer Center Survey and Data Management Core, Boston, Massachusetts, USA. 3. Yale School of Medicine, New Haven, Connecticut, USA. 4. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Division of Palliative Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. 5. Harvard Medical School, Boston, Massachusetts, USA; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. 6. Harvard Medical School, Boston, Massachusetts, USA; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address: oreofe_odejide@dfci.harvard.edu.
Abstract
CONTEXT: Patients with blood cancers have low rates of timely hospice use. Barriers to hospice use for this population are not well understood. Lack of transfusion access in most hospice settings is posited as a potential reason for low and late enrollment rates. OBJECTIVES: We explored the perspectives of patients with blood cancers and their bereaved caregivers regarding the value of hospice services and transfusions. METHODS: Between June 2018 and January 2019, we conducted three focus groups with blood cancer patients with an estimated life expectancy of six months or less and two focus groups with bereaved caregivers of patients with blood cancers. We asked participants their perspectives regarding quality of life (QOL) and about the potential association of traditional hospice services and transfusions with QOL. A hematologic oncologist, sociologist, and qualitatively trained research assistant conducted thematic analysis of the data. RESULTS: Twenty-seven individuals (18 patients and nine bereaved caregivers) participated in the five focus groups. Participants identified various QOL domains that were important to them but focused largely on a desire for energy to maintain physical/functional well-being. Participants considered transfusions a high-priority service for their QOL. They also felt that standard hospice services were important for QOL. Bereaved caregivers reported overall positive experiences with hospice. CONCLUSION: Our analysis suggests that although patients with blood cancers value hospice services, they also consider transfusions vital to their QOL. Innovative care delivery models that combine the elements of standard hospice services with other patient-valued services like transfusions are most likely to optimize end-of-life care for patients with blood cancers.
CONTEXT: Patients with blood cancers have low rates of timely hospice use. Barriers to hospice use for this population are not well understood. Lack of transfusion access in most hospice settings is posited as a potential reason for low and late enrollment rates. OBJECTIVES: We explored the perspectives of patients with blood cancers and their bereaved caregivers regarding the value of hospice services and transfusions. METHODS: Between June 2018 and January 2019, we conducted three focus groups with blood cancerpatients with an estimated life expectancy of six months or less and two focus groups with bereaved caregivers of patients with blood cancers. We asked participants their perspectives regarding quality of life (QOL) and about the potential association of traditional hospice services and transfusions with QOL. A hematologic oncologist, sociologist, and qualitatively trained research assistant conducted thematic analysis of the data. RESULTS: Twenty-seven individuals (18 patients and nine bereaved caregivers) participated in the five focus groups. Participants identified various QOL domains that were important to them but focused largely on a desire for energy to maintain physical/functional well-being. Participants considered transfusions a high-priority service for their QOL. They also felt that standard hospice services were important for QOL. Bereaved caregivers reported overall positive experiences with hospice. CONCLUSION: Our analysis suggests that although patients with blood cancers value hospice services, they also consider transfusions vital to their QOL. Innovative care delivery models that combine the elements of standard hospice services with other patient-valued services like transfusions are most likely to optimize end-of-life care for patients with blood cancers.
Authors: Sean A Fletcher; Angel M Cronin; Amer M Zeidan; Oreofe O Odejide; Steven D Gore; Amy J Davidoff; David P Steensma; Gregory A Abel Journal: Cancer Date: 2016-02-23 Impact factor: 6.860
Authors: Maria Dans; Thomas Smith; Anthony Back; Justin N Baker; Jessica R Bauman; Anna C Beck; Susan Block; Toby Campbell; Amy A Case; Shalini Dalal; Howard Edwards; Thomas R Fitch; Jennifer Kapo; Jean S Kutner; Elizabeth Kvale; Charles Miller; Sumathi Misra; William Mitchell; Diane G Portman; David Spiegel; Linda Sutton; Eytan Szmuilowicz; Jennifer Temel; Roma Tickoo; Susan G Urba; Elizabeth Weinstein; Finly Zachariah; Mary Anne Bergman; Jillian L Scavone Journal: J Natl Compr Canc Netw Date: 2017-08 Impact factor: 11.908
Authors: Holly L Geyer; Robyn M Scherber; Amylou C Dueck; Jean-Jacques Kiladjian; Zhijian Xiao; Stefanie Slot; Sonja Zweegman; Federico Sackmann; Ana Kerguelen Fuentes; Dolores Hernández-Maraver; Konstanze Döhner; Claire N Harrison; Deepti Radia; Pablo Muxi; Carlos Besses; Francisco Cervantes; Peter L Johansson; Bjorn Andreasson; Alessandro Rambaldi; Tiziano Barbui; Alessandro M Vannucchi; Francesco Passamonti; Jan Samuelsson; Gunnar Birgegard; Ruben A Mesa Journal: Blood Date: 2014-02-19 Impact factor: 22.113
Authors: Oreofe O Odejide; Angel M Cronin; Craig C Earle; Ann S LaCasce; Gregory A Abel Journal: J Natl Cancer Inst Date: 2015-10-05 Impact factor: 13.506
Authors: Rong Wang; Amer M Zeidan; Stephanie Halene; Xiao Xu; Amy J Davidoff; Scott F Huntington; Nikolai A Podoltsev; Cary P Gross; Steven D Gore; Xiaomei Ma Journal: J Clin Oncol Date: 2017-08-07 Impact factor: 44.544
Authors: Alison E Kris; Emily J Cherlin; Holly Prigerson; Melissa D A Carlson; Rosemary Johnson-Hurzeler; Stanislav V Kasl; Elizabeth H Bradley Journal: Am J Geriatr Psychiatry Date: 2006-03 Impact factor: 4.105
Authors: Michael J Hochman; Yinxi Yu; Steven P Wolf; Greg P Samsa; Arif H Kamal; Thomas W LeBlanc Journal: J Pain Symptom Manage Date: 2017-09-05 Impact factor: 3.612
Authors: Sarah D Kowitt; Katrina R Ellis; Veronica Carlisle; Nivedita L Bhushan; Kristin Z Black; Kaitlyn Brodar; Nicole M Cranley; Kia L Davis; Eugenia Eng; Michelle Y Martin; Jared McGuirt; Rebeccah L Sokol; Patrick Y Tang; Anissa I Vines; Jennifer S Walker; Edwin B Fisher Journal: Support Care Cancer Date: 2018-10-06 Impact factor: 3.603
Authors: Caroline Lefeuvre; Hélène De Pauw; Anne-Sophie Le Duc Banaszuk; Adeline Pivert; Alexandra Ducancelle; Franck Rexand-Galais; Marc Arbyn Journal: Int J Public Health Date: 2022-02-24 Impact factor: 3.380